+Follow
zrong
No personal profile
3
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
zrong
2021-05-11
Nice
Sorry, the original content has been removed
zrong
2021-05-11
Nice
China moves to regulate all synthetic cannabinoids
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3583806914595176","uuid":"3583806914595176","gmtCreate":1620712890165,"gmtModify":1620714575362,"name":"zrong","pinyin":"zrong","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/bdb35a6cc06a657f030af79578ea2617","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":2,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":199272687,"gmtCreate":1620713205049,"gmtModify":1704347179362,"author":{"id":"3583806914595176","authorId":"3583806914595176","name":"zrong","avatar":"https://static.tigerbbs.com/bdb35a6cc06a657f030af79578ea2617","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583806914595176","authorIdStr":"3583806914595176"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/199272687","repostId":"2134052657","repostType":4,"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":199276527,"gmtCreate":1620713154969,"gmtModify":1704347178865,"author":{"id":"3583806914595176","authorId":"3583806914595176","name":"zrong","avatar":"https://static.tigerbbs.com/bdb35a6cc06a657f030af79578ea2617","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583806914595176","authorIdStr":"3583806914595176"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/199276527","repostId":"2134650894","repostType":4,"repost":{"id":"2134650894","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1620710914,"share":"https://ttm.financial/m/news/2134650894?lang=&edition=fundamental","pubTime":"2021-05-11 13:28","market":"hk","language":"en","title":"China moves to regulate all synthetic cannabinoids","url":"https://stock-news.laohu8.com/highlight/detail?id=2134650894","media":"Reuters","summary":"BEIJING, May 11 (Reuters) - China will become the world's first country to regulate all synthetic ca","content":"<p>BEIJING, May 11 (Reuters) - China will become the world's first country to regulate all synthetic cannabinoid substances, in a bid to get ahead of new variations whose chemical properties are not yet subject to regulation, the country's drugs control office said on Tuesday.</p><p>Synthetic cannabinoids are lab-made drugs originally designed to produce similar effects to cannabis, but which are often far stronger and carry a greater health risk, Deng Ming, deputy director of China's National Narcotics Control Commission, said at a briefing.</p><p>By the end of 2020, 1047 variations had appeared worldwide, Deng said. Some of the drugs in China were being produced domestically, though some were also being smuggled from abroad, he added.</p><p>Abuse of the drug has been particularly prevalent in China's western Xinjiang region, where police have seized 16 kilos of the drug and arrested 390 suspects since 2018, Yu Haibin, another official, said.</p><p>Substances were often disguised to look like liquid used in e-cigarettes, Yu said.</p><p>In April 2019 China added fetanyl-related substances to a list of controlled narcotics drugs, after criticism from former U.S. President Donald Trump for allowing the synthetic opioid to be shipped to the United States.</p><p>The number of drug users in China has dropped in recent years from around four million to <a href=\"https://laohu8.com/S/AONE\">one</a> million, another official said, without specifying the time frame for the drop.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China moves to regulate all synthetic cannabinoids</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina moves to regulate all synthetic cannabinoids\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-11 13:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, May 11 (Reuters) - China will become the world's first country to regulate all synthetic cannabinoid substances, in a bid to get ahead of new variations whose chemical properties are not yet subject to regulation, the country's drugs control office said on Tuesday.</p><p>Synthetic cannabinoids are lab-made drugs originally designed to produce similar effects to cannabis, but which are often far stronger and carry a greater health risk, Deng Ming, deputy director of China's National Narcotics Control Commission, said at a briefing.</p><p>By the end of 2020, 1047 variations had appeared worldwide, Deng said. Some of the drugs in China were being produced domestically, though some were also being smuggled from abroad, he added.</p><p>Abuse of the drug has been particularly prevalent in China's western Xinjiang region, where police have seized 16 kilos of the drug and arrested 390 suspects since 2018, Yu Haibin, another official, said.</p><p>Substances were often disguised to look like liquid used in e-cigarettes, Yu said.</p><p>In April 2019 China added fetanyl-related substances to a list of controlled narcotics drugs, after criticism from former U.S. President Donald Trump for allowing the synthetic opioid to be shipped to the United States.</p><p>The number of drug users in China has dropped in recent years from around four million to <a href=\"https://laohu8.com/S/AONE\">one</a> million, another official said, without specifying the time frame for the drop.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2134650894","content_text":"BEIJING, May 11 (Reuters) - China will become the world's first country to regulate all synthetic cannabinoid substances, in a bid to get ahead of new variations whose chemical properties are not yet subject to regulation, the country's drugs control office said on Tuesday.Synthetic cannabinoids are lab-made drugs originally designed to produce similar effects to cannabis, but which are often far stronger and carry a greater health risk, Deng Ming, deputy director of China's National Narcotics Control Commission, said at a briefing.By the end of 2020, 1047 variations had appeared worldwide, Deng said. Some of the drugs in China were being produced domestically, though some were also being smuggled from abroad, he added.Abuse of the drug has been particularly prevalent in China's western Xinjiang region, where police have seized 16 kilos of the drug and arrested 390 suspects since 2018, Yu Haibin, another official, said.Substances were often disguised to look like liquid used in e-cigarettes, Yu said.In April 2019 China added fetanyl-related substances to a list of controlled narcotics drugs, after criticism from former U.S. President Donald Trump for allowing the synthetic opioid to be shipped to the United States.The number of drug users in China has dropped in recent years from around four million to one million, another official said, without specifying the time frame for the drop.","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":199272687,"gmtCreate":1620713205049,"gmtModify":1704347179362,"author":{"id":"3583806914595176","authorId":"3583806914595176","name":"zrong","avatar":"https://static.tigerbbs.com/bdb35a6cc06a657f030af79578ea2617","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583806914595176","authorIdStr":"3583806914595176"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/199272687","repostId":"2134052657","repostType":4,"repost":{"id":"2134052657","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1620710378,"share":"https://ttm.financial/m/news/2134052657?lang=&edition=fundamental","pubTime":"2021-05-11 13:19","market":"us","language":"en","title":"Vaccines company Valneva announces closing of its $107.6 mln global public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2134052657","media":"T-Reuters","summary":"Valneva SE:Valneva Announces Closing Of $107.6 Million Global Offering.Valneva Announces Closing Of ","content":"<p><a href=\"https://laohu8.com/S/VNVLF\">Valneva SE</a>:Valneva Announces Closing Of $107.6 Million Global Offering.Valneva Announces Closing Of $107.6 Million Global Offering.Offering Price Of $26.41 Per Ads.Goldman Sachs, Jefferies, Guggenheim Securities And Bryan, Garnier & Co. Acted As Joint Bookrunners For The Global Offering. Namsen Capital Acted As Valneva’S Capital Markets Advisor..</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccines company Valneva announces closing of its $107.6 mln global public offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccines company Valneva announces closing of its $107.6 mln global public offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-05-11 13:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/VNVLF\">Valneva SE</a>:Valneva Announces Closing Of $107.6 Million Global Offering.Valneva Announces Closing Of $107.6 Million Global Offering.Offering Price Of $26.41 Per Ads.Goldman Sachs, Jefferies, Guggenheim Securities And Bryan, Garnier & Co. Acted As Joint Bookrunners For The Global Offering. Namsen Capital Acted As Valneva’S Capital Markets Advisor..</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2134052657","content_text":"Valneva SE:Valneva Announces Closing Of $107.6 Million Global Offering.Valneva Announces Closing Of $107.6 Million Global Offering.Offering Price Of $26.41 Per Ads.Goldman Sachs, Jefferies, Guggenheim Securities And Bryan, Garnier & Co. Acted As Joint Bookrunners For The Global Offering. Namsen Capital Acted As Valneva’S Capital Markets Advisor..","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":199276527,"gmtCreate":1620713154969,"gmtModify":1704347178865,"author":{"id":"3583806914595176","authorId":"3583806914595176","name":"zrong","avatar":"https://static.tigerbbs.com/bdb35a6cc06a657f030af79578ea2617","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583806914595176","authorIdStr":"3583806914595176"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/199276527","repostId":"2134650894","repostType":4,"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
